Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET

Company Participants

Robert Borchert – Senior Vice President-Investor and Corporate Communications

Shawn Morris – Chief Executive Officer

Parth Mehrotra – President and Chief Operating Officer

David Mountcastle – Chief Financial Officer

Conference Call Participants

Josh Raskin – Nephron Research

A.J. Rice – Credit Suisse

Lisa Gill – J.P. Morgan

Ryan Daniels – William Blair

Whit Mayo – SVB Securities

Jessica Tassan – Piper Sandler

Sandy Draper – Guggenheim

Adam Ron – Bank of America

David Larsen – BTIG

Richard Close – Canaccord

Brian Tanquilut – Jefferies

Operator

Good day and thank you for standing by. Welcome to the Privia Health Q1 2022 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Robert Borchert, SVP of Investor and Corporate Communications. Please go ahead.

Robert Borchert

Thank you, Gigi, and good morning, everyone. Joining me today are Shawn Morris, our Chief Executive Officer; Parth Mehrotra, President and Chief Operating Officer; and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed from the Investor Relations section of priviahealth.com. Today's press release highlighting our financial and operating performance and the slide presentation accompanying our formal remarks are posted on our IR website.

Following our prepared comments, we will open line for questions. We ask that you please limit yourself to one question and one follow-up, so we can get through the queue in a timely fashion. The financial results reported today and in the press release are preliminary and are not final until our Form 10-Q for the quarter ended March 31, 2022, is filed with the Securities and Exchange Commission. Some of the statements we will make today are forward-looking in nature based on our current expectations and our view of our business as of May 12, 2022.

Such statements, including those related to our future financial and operating performance and future business plans and objectives, are subject to risks and uncertainties that may cause actual results to differ materially. As a result, these statements should be considered in conjunction with the cautionary statements in today's press release and the risk factors described in our company's most recent SEC filings. Finally, we may refer to certain non-GAAP financial measures on the call, and reconciliations of these measures to comparable GAAP measures are included in our press release and the accompanying slide presentation posted on our website.